financetom
Business
financetom
/
Business
/
Palantir Technologies Insider Sold Shares Worth $1,490,101, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Palantir Technologies Insider Sold Shares Worth $1,490,101, According to a Recent SEC Filing
Jan 7, 2025 12:43 AM

03:16 AM EST, 01/07/2025 (MT Newswires) -- Alexander D. Moore, Director, on January 02, 2025, sold 20,000 shares in Palantir Technologies ( PLTR ) for $1,490,101. Following the Form 4 filing with the SEC, Moore has control over a total of 1,430,630 shares of the company, with 1,430,630 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1321655/000132165525000003/xslF345X05/wk-form4_1736212045.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Voya Financial Q3 adjusted EPS rises nearly 30% on higher fee income, raises dividend
Voya Financial Q3 adjusted EPS rises nearly 30% on higher fee income, raises dividend
Nov 4, 2025
Overview * Voya Q3 adjusted operating EPS grows nearly 30% yr/yr, driven by segment earnings growth * Company generated over $200 mln excess capital in Q3, reflecting strong financial position * Voya increases quarterly dividend by 4% to $0.47 per share, starting Q4 2025 Outlook * Company confident in long-term growth due to strategic investments and strong balance sheet Result...
Corcept Therapeutics misses Q3 revenue expectations, modifies 2025 revenue forecast
Corcept Therapeutics misses Q3 revenue expectations, modifies 2025 revenue forecast
Nov 4, 2025
Overview * Corcept Q3 2025 revenue of $207.6 mln, missed analyst expectations * Net income for Q3 2025 decreased to $19.7 mln from $47.2 mln last year * Company expands oncology programs with new cancer studies Outlook * Corcept modifies 2025 revenue guidance to $800 mln - $850 mln * Company expects to meet increasing demand with new specialty pharmacies...
Assurant Q3 Adjusted Earnings, Revenue Rise
Assurant Q3 Adjusted Earnings, Revenue Rise
Nov 4, 2025
04:43 PM EST, 11/04/2025 (MT Newswires) -- Assurant ( AIZ ) reported Q3 adjusted earnings late Tuesday of $5.73 per diluted share, up from $3.00 a year earlier. Analysts polled by FactSet expected $4.37. Revenue in the three months ended Sept. 30 rose to $3.23 billion from $2.97 billion a year earlier. Analysts surveyed by FactSet expected $3.19 billion. Assurant...
Contract logistics provider GXO beats Q3 revenue estimates, reaffirms full-year guidance
Contract logistics provider GXO beats Q3 revenue estimates, reaffirms full-year guidance
Nov 4, 2025
Overview * GXO Q3 revenue rose 8% to $3.4 bln, beating analyst expectations * Adjusted EPS for Q3 met analyst expectations at $0.79 * Adjusted EBITDA for Q3 beat estimates, highlighting strong operational performance Outlook * GXO reaffirms full-year 2025 guidance with organic revenue growth of 3.5% to 6.5% * Company expects adjusted EBITDA of $865 mln to $885 mln...
Copyright 2023-2026 - www.financetom.com All Rights Reserved